NIHR | Manchester Biomedical Research Centre

News & Events Category:
Musculoskeletal

Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination

Posted: Monday, July 11, 2022

A major clinical trial supported by Manchester BRC researchers has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.

Taking charge of arthritis – Dr James Bluett speaks to Arthritis Digest

Posted: Friday, May 13, 2022

BRC Musculoskeletal researcher Dr James Bluett talks to Arthritis Digest magazine about how new tests will support patients with rheumatoid arthritis to regain control of their health.

Manchester BRC musculoskeletal researchers publish ‘ground-breaking’ national guidelines for myositis

Posted: Wednesday, May 11, 2022

Researchers from Manchester BRC’s Musculoskeletal (MSK) Theme have published the first guidelines on the care and treatment of patients with the rare autoimmune condition, myositis.

Myositis and remote patient monitoring – Dr Alexander Oldroyd speaks to Arthritis Digest

Posted: Monday, March 14, 2022

Continuing regular contributions from our BRC Musculoskeletal (MSK) theme researchers, Dr Alexander Oldroyd speaks to Arthritis Digest magazine about how technology could potentially help predict flares in patients with the autoimmune condition, myositis.

Manchester BRC researchers receive prestigious national appointments

Posted: Monday, March 14, 2022

Three researchers from Manchester Biomedical Research Centre (BRC) have been appointed Senior Investigators by the National Institute for Health Research (NIHR).

UK collaboration sees NIHR IMID BioResource pass major recruitment milestone

Posted: Tuesday, February 15, 2022

The NIHR Immune Mediated Inflammatory Disease (IMID) BioResource recently hit a major recruitment milestone of 2000 volunteers, thanks to the collaborative effort of centres across England.

Study profiles side-effects linked to common immunosuppressant methotrexate

Posted: Thursday, January 27, 2022

New research led by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) scientists has profiled the side effects of methotrexate – a common drug used to treat arthritis and other autoimmune diseases.

From Manchester to Toronto – Improving lupus ‘brain fog’

Posted: Tuesday, January 18, 2022 Author: Dr Michelle Barraclough

Dr Michelle Barraclough, Research Associate for Manchester BRC’s Musculoskeletal theme, shares her work on improving 'brain fog' for lupus patients, as part of a year-long research placement in Toronto, Canada.

News & Events Category: Musculoskeletal

News & Events Category:
Musculoskeletal